Gilder Gagnon Howe & Co. LLC Lowers Holdings in Oscar Health, Inc. $OSCR

Gilder Gagnon Howe & Co. LLC decreased its position in Oscar Health, Inc. (NYSE:OSCR) by 21.8% during the second quarter, HoldingsChannel.com reports. The firm owned 4,909,743 shares of the company’s stock after selling 1,372,074 shares during the quarter. Oscar Health makes up approximately 1.1% of Gilder Gagnon Howe & Co. LLC’s holdings, making the stock its 23rd largest holding. Gilder Gagnon Howe & Co. LLC’s holdings in Oscar Health were worth $105,265,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also bought and sold shares of OSCR. BNP Paribas Financial Markets raised its holdings in Oscar Health by 42.5% in the second quarter. BNP Paribas Financial Markets now owns 26,151 shares of the company’s stock worth $561,000 after buying an additional 7,804 shares during the last quarter. Bienville Capital Management LLC bought a new stake in shares of Oscar Health during the second quarter valued at approximately $21,204,000. Brevan Howard Capital Management LP raised its holdings in Oscar Health by 927.2% in the 2nd quarter. Brevan Howard Capital Management LP now owns 465,218 shares of the company’s stock worth $9,974,000 after acquiring an additional 419,927 shares during the last quarter. Bank of America Corp DE lifted its position in Oscar Health by 48.9% in the 2nd quarter. Bank of America Corp DE now owns 823,832 shares of the company’s stock valued at $17,663,000 after acquiring an additional 270,533 shares in the last quarter. Finally, PDT Partners LLC boosted its stake in Oscar Health by 44.6% during the 2nd quarter. PDT Partners LLC now owns 424,569 shares of the company’s stock valued at $9,103,000 after purchasing an additional 130,896 shares during the last quarter. 75.70% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

OSCR has been the subject of several recent analyst reports. Piper Sandler upgraded Oscar Health from a “neutral” rating to an “overweight” rating and boosted their price target for the stock from $13.00 to $25.00 in a research note on Tuesday, November 25th. Weiss Ratings reiterated a “sell (d)” rating on shares of Oscar Health in a report on Wednesday, October 8th. Wall Street Zen cut shares of Oscar Health from a “hold” rating to a “sell” rating in a research note on Saturday, December 6th. Zacks Research raised shares of Oscar Health from a “strong sell” rating to a “hold” rating in a report on Monday, October 13th. Finally, The Goldman Sachs Group started coverage on shares of Oscar Health in a report on Tuesday, October 14th. They set a “neutral” rating and a $17.00 price objective for the company. One research analyst has rated the stock with a Buy rating, six have assigned a Hold rating and four have issued a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Reduce” and an average target price of $15.57.

Oscar Health Stock Up 4.6%

OSCR stock opened at $16.60 on Friday. The company has a market cap of $4.39 billion, a price-to-earnings ratio of -14.82 and a beta of 1.88. The company has a debt-to-equity ratio of 0.67, a quick ratio of 0.92 and a current ratio of 0.92. The business’s 50-day moving average is $17.70 and its two-hundred day moving average is $16.99. Oscar Health, Inc. has a fifty-two week low of $11.20 and a fifty-two week high of $23.80.

Oscar Health (NYSE:OSCR) last released its quarterly earnings results on Thursday, November 6th. The company reported ($0.53) EPS for the quarter, beating the consensus estimate of ($0.55) by $0.02. Oscar Health had a negative net margin of 2.16% and a negative return on equity of 21.50%. The firm had revenue of $2.93 billion during the quarter, compared to analyst estimates of $3.09 billion. During the same quarter in the prior year, the firm earned ($0.22) EPS. The business’s revenue for the quarter was up 23.2% compared to the same quarter last year. As a group, analysts forecast that Oscar Health, Inc. will post 0.69 earnings per share for the current year.

Insider Buying and Selling at Oscar Health

In other Oscar Health news, insider Adam Mcananey sold 1,852 shares of the company’s stock in a transaction that occurred on Tuesday, December 2nd. The shares were sold at an average price of $16.59, for a total transaction of $30,724.68. Following the completion of the sale, the insider directly owned 179,241 shares of the company’s stock, valued at approximately $2,973,608.19. This represents a 1.02% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CFO Richard Scott Blackley sold 25,135 shares of Oscar Health stock in a transaction on Tuesday, December 2nd. The stock was sold at an average price of $16.59, for a total transaction of $416,989.65. Following the transaction, the chief financial officer owned 1,351,034 shares in the company, valued at $22,413,654.06. This represents a 1.83% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold a total of 739,472 shares of company stock valued at $12,616,880 in the last ninety days. Corporate insiders own 24.39% of the company’s stock.

About Oscar Health

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.